
Andrea Franson, MD, discusses the mechanism of action of tovorafenib and its emerging role within the evolving treatment paradigm for pLGG.

Your AI-Trained Oncology Knowledge Connection!


Andrea Franson, MD is a clinical associate professor of pediatrics, fellowship director of Pediatric Hematology/Oncology, and a pediatric oncologist in the Department of Pediatrics at the University of Michigan Medical School.

Andrea Franson, MD, discusses the mechanism of action of tovorafenib and its emerging role within the evolving treatment paradigm for pLGG.